TFEB and breast carcinoma: Furthermore, our results strongly indicate that the mechanisms governing the subcellular localization and biological activity of TFEB in response to Tam treatment are shared by all the breast cancer cell lines tested, irrespectively of their susceptibility or resistance to the drug.